Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening
Open Access
- 16 April 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (16) , 10921-10935
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium f?r Bildung und Forschung
- Deutscher Akademischer Austauschdienst
This publication has 80 references indexed in Scilit:
- Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationACS Medicinal Chemistry Letters, 2012
- Synthesis, SAR and evaluation of [1,4′]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Discovery of novel (S)-α-phenyl-γ-amino butanamide containing CCR5 antagonists via functionality inversion approachBioorganic & Medicinal Chemistry Letters, 2010
- Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacyclesBioorganic & Medicinal Chemistry Letters, 2010
- Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment AssemblyMolecules, 2008
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneBioorganic & Medicinal Chemistry Letters, 2005
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Molecular recognition of receptor sites using a genetic algorithm with a description of desolvationJournal of Molecular Biology, 1995